Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial.
Publication
, Journal Article
Shah, MR; Claise, KA; Bowers, MT; Bhapkar, M; Little, J; Nohria, A; Gaulden, LH; McKee, VK; Cozart, KL; Mancinelli, KL; Daniels, H; Kinard, T ...
Published in: Am Heart J
November 2005
Duke Scholars
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
November 2005
Volume
150
Issue
5
Start / End Page
893 / 898
Location
United States
Related Subject Headings
- Natriuretic Peptide, Brain
- Humans
- Heart Failure
- Follow-Up Studies
- Disease Progression
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Shah, M. R., Claise, K. A., Bowers, M. T., Bhapkar, M., Little, J., Nohria, A., … Califf, R. M. (2005). Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial. Am Heart J, 150(5), 893–898. https://doi.org/10.1016/j.ahj.2005.01.003
Shah, Monica R., Karen A. Claise, Margaret T. Bowers, Manjushri Bhapkar, Julie Little, Anju Nohria, Laura H. Gaulden, et al. “Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial.” Am Heart J 150, no. 5 (November 2005): 893–98. https://doi.org/10.1016/j.ahj.2005.01.003.
Shah MR, Claise KA, Bowers MT, Bhapkar M, Little J, Nohria A, et al. Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial. Am Heart J. 2005 Nov;150(5):893–8.
Shah, Monica R., et al. “Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial.” Am Heart J, vol. 150, no. 5, Nov. 2005, pp. 893–98. Pubmed, doi:10.1016/j.ahj.2005.01.003.
Shah MR, Claise KA, Bowers MT, Bhapkar M, Little J, Nohria A, Gaulden LH, McKee VK, Cozart KL, Mancinelli KL, Daniels H, Kinard T, Stevenson LW, Mancini DM, O’Connor CM, Califf RM. Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial. Am Heart J. 2005 Nov;150(5):893–898.
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
November 2005
Volume
150
Issue
5
Start / End Page
893 / 898
Location
United States
Related Subject Headings
- Natriuretic Peptide, Brain
- Humans
- Heart Failure
- Follow-Up Studies
- Disease Progression
- Clinical Trials as Topic
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology